Compounding Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Are trying to create a robust commercial marketplace in lowearth orbit great we need spacex to get customers that are not nasa. We want to be a customer, but we want to be one of many customers. What we are doing is giving spacex a lot of leash. We have contracted for them to do the launch independently, but make no mistake, our engineers and our technicians have been involved in the developing of this capability, and our astronauts have been involved in it. We want to be one customer of many. We are helping to grow this commercial marketplace by being a tenant customer, but we also want to ha...

Theyre going to be talking about International Cooperation in space. So youre asking it in very general terms and, of course, with all these agencies oef here, there are already activities going on in cooperation not only on the International Space station but also in other programs so there are bilateral and multilateral agreements. If you ask concretely about gateway, this is another question. And for that, we are looking we are meeting already since now, since two, three years, at least, working on it, and this is more important than just the agreements. The agreements is something which ha...

Ok. Welcome, everybody. Thank you for being here. You heard the statements already, so the floor is yours and you can ask all of the questions you want. Please, raise your hand and tell , andur name and your media if you have a specific speaker he would like to answer your question. Thank you. I would like to start with administrator bridenstine. Everyone talks about the importance of exploration but words get transformed into concrete action like an extension of the iga, bilateral agreements, or something binding that gets the various agencies working together. I try to enter what your asking...

The drugs, Ozempic and Mounjaro, which are approved drugs to treat for type 2 diabetes, are sometimes prescribed off-label to overweight and obese people.

The government will ban compounding pharmacists from making replica versions of diabetes drugs like Ozempic and Mounjaro, widely used off-label for weight loss, amid public safety concerns.